Financials
Financial year 2023
Worth noting
- A loss two years in a row.
Revenue
€ 117,839
▲ 25% vs 2022
Profit
Caution€ -1.6 million
▲ 32% vs 2022
Debts
Low€ 1.5 million
▼ 25% vs 2022
EGEIRO PHARMA from Charleroi, company number BE0684906013, closed financial year 2023 with a result of € -1.6 million after tax. For that financial year EGEIRO PHARMA recorded revenue of € 117,839 and equity of € 6 million. Compared with financial year 2022, the result moved from € -2.3 million to € -1.6 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 8, 2024.
What happened at EGEIRO PHARMA?
What happened at EGEIRO PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Simon WHEELER stepped down as director. NBB
- NESYA GORIS LIFESCIENCES CONSULTING BV stepped down as director. NBB
- New annual accounts for financial year 2023: loss of € 1.6 million. filed late Source: NBB ↗
- ENRICO BASTIANELLI SRL stepped down as director. NBB
- CAPITAL ET CROISSANCE SCRL stepped down as director. NBB
- Julie WINAND stepped down as director. NBB
- Simon WHEELER became a director. NBB
- NESYA GORIS LIFESCIENCES CONSULTING BV became a director. NBB
In short
From € 1.3 million loss in 2021 to € 1.6 million loss in 2023.
Pays suppliers within 30 days on average.
A new publication or filing at EGEIRO PHARMA? We notify you, reason included.
Follow EGEIRO PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of THERAVET US A, INC (Corporation) itself.
Directors
According to the 2023 annual accounts
since 2017 · until 2023
Simon WHEELER
Director
since 2021 · until 2026
Director · represented by MATHIEU JEAN-PHILIPPE
Also active at: CONCEPTEXPO GROUP, COLONA, MEGAFORM +34 more
since 2017 · until 2023
NESYA GORIS LIFESCIENCES CONSULTING BV
Director · represented by Nesya GORIS
since 2021 · until 2026
Director · represented by BASTIANELLI ENRICO
Also active at: APAXEN, MitralShape, DERMANOVE
since 2017 · until 2024
Establishments
Establishment units
Physical locations of this company
Avenue Jean Mermoz 32 box 1
6041 Charleroi
Researchdreef 4
1070 Anderlecht
Active since 1 July 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Details
- Company number
- 0684.906.013
- VAT number
- BE 0684.906.013
- Registered office
- Avenue Jean Mermoz 32 bus 1, 6041 Charleroi
- Names & denominations
- EGEIRO PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 22 November 2017
- Peppol
- Not registered
- Activities · NACE
Vervaardiging van andere anorganische chemische basisproducten